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Key Points
•Nbeal2 deficiency
leads to significantly
reduced lung and brain
pathology and en-
hanced survival in
a mouse model of
malaria.
•Both antibody-
dependent and
antibody-independent
platelet depletion in
mice recapitulate the
findings observed in
Nbeal22/2 mice.
Introduction
Cerebral malaria and malaria-associated acute lung injury/acute respiratory distress syndrome are
among the most severe complications of Plasmodium infection. While these disease manifestations are
multifactorial, platelets have been described to play a role in the development of both syndromes in
humans1,2 and mice.3,4 Although the impact of platelets on malaria has been well studied, questions
remain with regard to their contribution to parasite control and immunopathogenesis. Studies have
indicated that platelets can kill Plasmodium-infected red blood cells (iRBCs).5-8 However, there are
contrasting reports that platelets do not exert any significant control over parasite growth but rather
exacerbate malaria immunopathology.3,9-12 In this study, we address the role of platelets in the
development of severe malaria in 3 different mouse models of platelet dysfunction/depletion. We
show a key role for platelets, particularly platelet a-granules, in mediating organ-specific pathologies
during rodent Plasmodium infection.
Methods
Rodent Plasmodium infection
Female C57BL/6J mice aged 6 to 12 weeks were bred in-house or purchased from The Jackson
Laboratory. Homozygous Nbeal22/2 mice on a C57BL/6J background originated from the Di Paola
laboratory and were obtained by Robert Campbell to be bred in-house. C57BL/6-Tg(PF4-icre)Q3Rsko/J
mice (platelet factor 4 [PF4] Cre, Stock 008535) and C57BL/6-Gt(ROSA)26Sortm1(HBEGF)Awai/J mice
(B6-iDTR, stock 007900) were purchased from The Jackson Laboratory. Homozygous B6-iDTR mice
were bred with PF4-Cre positive or negative mice to generate PF4-Cre–positive inducible diphtheria
toxin receptor (iDTR)–positive and PF4-Cre–negative iDTR-negative mice. Infections were initiated
intraperitoneally with 0.5 3 106 Plasmodium berghei ANKA (PbA) iRBCs (clone15cy1, 1037cl1
WT-GFP-Lucschiz; mutant RMgm-32, or a constitutive GFP-expressing clone) obtained from donor
C57BL/6J mice. Peripheral parasitemia was monitored by counting 300 to 500 red blood cells (RBCs)
on Diff-Quik (Siemens)–stained thin blood smears. All experiments were carried out according to
protocols approved by the institutional animal care and use committees and biosafety committees
of Emory University (DAR-2000454-021114BN, HAD01-2425-11R15-101915) and the University of
Utah (17-01001, 05-17).
Tissue preparation for flow cytometry
Spleens were pressed through a 40-mm cell strainer and suspended in Iscove modified Dulbecco
medium (IMDM) containing 100 U/mL penicillin, 100 mg/mL streptomycin, 1 mM L-glutamine, 12 mM
N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid, 0.5 mM sodium pyruvate, and 5 3 1025 M
2-mercaptoethanol (all Gibco) (cIMDM). Single-cell suspensions of splenocytes were centrifuged
at 1500 rpm for 8 minutes at 4°C prior to RBC lysis of the pellet using an RBC lysis buffer (BioLegend).
Submitted 2 August 2019; accepted 19 November 2019; published online
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Figure 1. Nbeal2 deficiency significantly alters parasite sequestration, lung and brain pathology, and survival in PbA-infected mice. (A) Time course of platelets
in peripheral blood of C57BL/6J mice after PbA infection compared with naive control mice (n 5 7-10 mice/group) as determined by flow cytometry. (B) Platelets in whole
blood of naive Nbeal22/2 mice normalized to naive C57BL/6J (B6) control mice as determined by flow cytometry (n 5 20-24 mice/group). (C) Frequency of platelet-iRBC
conjugates (left, n 5 10-20 mice/group) in whole blood of C57BL/6J and Nbeal22/2 mice after PbA-GFP infection and time course of peripheral parasitemia as determined by
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Splenocytes were centrifuged again before resuspension in cIMDM
with the addition of 10% heat-inactivated fetal calf serum (HI-FCS)
(PAA Laboratories) for downstream flow cytometric analysis. Brains
were pressed through a 100-mm cell strainer and resuspended in
a 30% Percoll solution before overlaying onto a 70% Percoll gradient.
Brain samples were centrifuged at 600g for 20 minutes at room
temperature with no brake. The peripheral blood mononuclear cell
interface was collected and washed with cIMDM 1 HI-FCS before
resuspension in cIMDM 1 HI-FCS for downstream flow cytometric
analysis. Lungs were placed in a 6-well plate and minced with scissors
prior to incubation in digestion media (RPMI1 collagenase D [Roche]
1 DNase [Invitrogen]) at 37°C for 30 minutes in a shaking incubator.
Cells were filtered through a 100-mm cell strainer and centrifuged
at 1500 rpm for 8 minutes at 4°C. The pellet was then resuspended
in a 40% Percoll solution before overlaying onto an 80% Percoll
gradient. Lung samples were centrifuged at 1600 rpm for 25 minutes
at room temperature with no brake. The interface was collected and
washed prior to RBC lysis and resuspension in cIMDM 1 HI-FCS
for downstream flow cytometric analysis.
Flow cytometry staining
Whole blood (5 mL) was collected into Krebs saline containing
antibodies of interest for staining. Platelet depletion efficacy
was determined by size and granularity and CD41 expression
(phycoerythrin [PE], Pacific Blue, or BV421, cl. MWReg30) via flow
cytometry. For time-course experiments monitoring platelet-iRBC
aggregation and platelet activation, the following additional anti-
bodies were used: TER-119 (APC/Cy7 or BV786, cl. TER-119),
CD62P/P-selectin (PE or PE/Cy7, cl. RMP-1), CD63 (APC, cl. NVG-2)
(all from BioLegend), and aIIbb3 (PE, cl. JON/A) (EmFret). A PbA
clone expressing constitutive GFP (PbA-GFP) was used for infections
in which parasites were detected via flow cytometry. For neutrophil
sequestration experiments, the following antibodies were used: Ly-6G
(PE, cl. 1A8), CD11b (BV605, cl. M1/70), CD19 (BV510, cl. 6D5),
Ly-6C (PerCP/Cy5.5, cl. HK1.4), and Zombie NIR viability dye (all
from BioLegend).
Imaging flow cytometry
Experiments were performed on an ImageStreamX Mk II imaging
flow cytometer with INSPIRE acquisition software (Amnis), which
allows for distinguishing coincident vs contact events. All images
were captured with the 603 objective. Whole blood (5 mL) was
collected into Krebs saline containing antibodies of interest for staining.
The following antibodies were used: CD41-BV421 (cl. MWReg30,
to identify platelets) and TER-119-AF647 (cl. TER-119, to identify
red blood cells) (both from BioLegend), in addition to the PbA-GFP
fluorescent parasite to identify infected red blood cells. BV421 was
excited by the 405-nm laser and emission captured in the range
435 to 505 nm (Ch1), GFP was excited by the 488-nm laser and
emission captured in the range 505 to 560 nm (Ch2), AF647 was
excited by the 642-nm laser and emission captured in the range 642 to
745 nm (Ch5), and bright field was captured in Ch3. Single-stained
controls were used to generate a compensation matrix. IDEAS v6.2
software (Amnis) was used for data analysis on compensated data.
ELISA
Mouse PF4, elastase, and myeloperoxidase enzyme-linked immuno-
sorbent assay (ELISA) kits (all from R&DSystems) were used to detect
these molecules in plasma of mice according to the manufacturer’s
instructions.
Bioluminescent parasite imaging
Parasite burden in tissues was determined using an IVIS Spectrum
Bioluminescent Imaging System (PerkinElmer). At days 2, 4, or 6 after
infection with the PbA schizont-specific luciferase reporter line, mice
were injected with 150 mL RediJect D-Luciferin bioluminescent
substrate (PerkinElmer) 30 minutes prior to euthanization, organ
dissection, and imaging. Regions of intensity were quantified using
IVIS Living Image software.
In vivo platelet/megakaryocyte depletion
C57BL/6J mice were intraperitoneally injected with 0.1 mg purified
anti-mouse CD41 antibody (clone MWReg30, BioLegend) or
isotype control antibody (rat immunoglobulin G1, k, BioLegend)
1 day after infection with PbA. PF4-Cre–positive iDTR-positive ((2)
MK) mice and PF4-Cre–negative iDTR-negative ((1) MK) mice
were intraperitoneally injected with 20 ng diphtheria toxin (Sigma)
on days 27, 24, and 21 prior to infection with PbA.
In vivo Evans blue permeability assay
Mice were injected IV with 200 mL of 1% Evans blue (Sigma) on day 6
after infection with PbA and euthanized 1 hour later. Brains and lungs
were removed and imaged using a MicroCapture digital micro-
scope (Veho) and placed into vials containing 1 mL formamide
(Sigma) at 37°C for 4 days. The concentration of the dye extracted
from the tissues was measured at an absorbance of 620 nm using
a plate reader (Biotek).
Results and discussion
Previous studies in mice have demonstrated the importance of
platelets in the development of severe malaria pathology even as
Figure 1. (continued) staining and counting of thin blood smears (right, n 5 10 mice/group). (D) Representative flow cytometry plots and quantification of the frequency of
P-selectin1, CD631, and CD41/CD611 platelets as well as total platelets normalized to control mice in whole blood isolated from C57BL/6J (B6) and Nbeal22/2 mice at day 5 after
infection with PbA (n 5 10-26 mice/group). (E) Quantification of PF4 in the plasma of C57BL/6J and Nbeal22/2 mice at day 6 after infection with PbA (n 5 10-14 mice/group) or naive
(N) (n 5 9-10 mice/group) as determined by ELISA. (F-H) Representative images and bioluminescence quantification of sequestered PbA schizonts expressing luciferase under the
AMA-1 promoter in spleens (F), lungs (G), and brains (H) of PbA-infected C57BL/6J (B6) and Nbeal22/2 mice (n 5 8 mice/group). Values are normalized to naive control mice from
each respective group (n 5 4 mice/group). (I-J) Lung permeability (I) and brain permeability (J) in C57BL/6J (B6) and Nbeal22/2 mice injected IV with 200 mL of 1% Evans blue dye
at day 6 after infection with PbA (n 5 9-13/group). Representative images and quantification of dye extracted from whole organs are shown. Optical density values are normalized to
naive control mice from each respective group (n 5 4 mice/group). (K) Survival curves of PbA-infected Nbeal22/2 (blue line) and C57BL/6J (B6, red line) mice (n 5 15-16 mice/group).
The gray shaded region represents the typical timeframe of death from ECM. Graphs in panels A-E and I-J represent the mean 6 standard error of the mean. Boxes in panels
F-H represent the median 6 the 25th and 75th percentiles with minimum/maximum whiskers. Statistical analyses were performed using the Mann-Whitney U test (A-J) and log-rank
Mantel-Cox test (K). Only statistically significant (P , .05) values are shown. For graphs in panels A and C, *P , .05, **P , .005, ***P , .0005, and ****P , .0001. Figures
represent combined data from 2 (A; C, right; D, middle and right graphs; and E-J) or $3 (B; C, left; D, left; and K) independent experiments. P.I., postinfection; SSC, side scatter.
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Figure 2. Platelet depletion recapitulates the reduced organ pathology and increased survival observed in Nbeal22/2 mice. (A) Representative flow cytometry
plots of platelets in mouse whole blood when platelets are present (left, platelet intact mice) or absent (right, megakaryocyte/platelet–depleted mice). Platelets in whole blood
of platelet-depleted anti-CD41–treated C57BL/6J mice (a-CD41) and diphtheria toxin–treated (2) MK mice normalized to their respective platelet intact control groups as
quantified by flow cytometry (n 5 29-37 mice/group). C57BL/6J mice were intraperitoneally injected with 100 mg of either an anti-CD41 or isotype control antibody on day 1
after PbA infection, and platelets were measured on day 3 after PbA infection. PF4-Cre–negative iDTR ((1) MK) (megakaryocyte and platelet sufficient) and (2) MK (megakar-
yocyte and platelet deficient) mice were intraperitoneally injected with 20 ng diphtheria toxin on days 27, 24, and 21 prior to PbA infection, and platelets were measured
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platelet counts decrease significantly over the course of Plasmodium
infection,9 which is a phenomenon we also observed (Figure 1A).
In order to investigate how platelets and platelet a-granules may
function to mediate severe malaria pathogenesis, we used PbA,
a parasite strain that causes a well-established mouse model of
experimental cerebral malaria (ECM)13 and lung injury,14,15 to infect
wild-type C57BL/6J mice along with neurobeachin-like 2 (Nbeal2)–
deficient mice, which have severe defects in platelet a-granule
formation.16,17 Naive Nbeal22/2 mice had a slight but significant
reduction in platelets compared with naive control mice (Figure 1B).
Upon infection with PbA, we observed a significantly lower frequency
of platelet-iRBC conjugates in whole blood isolated from Nbeal22/2
mice compared with C57BL/6J mice (Figure 1C, left), even though
there were no significant differences in peripheral parasitemia
between the 2 groups over the course of infection (Figure 1C, right).
Additionally, we confirmed using imaging flow cytometry that .90%
of platelet-iRBC double-positive events indeed represented platelets
in contact with iRBCs (supplemental Figure 1). While we cannot
conclusively determine whether platelets become activated sub-
sequent to contact with iRBCs or if activated platelets preferentially
bind to iRBCs, these data indicate that platelet a-granules can
impact the ability of platelets to interact with iRBCs. However, this
interaction between platelets and iRBCs has no effect on overall
peripheral parasite growth, which supports previous findings.9
P-selectin (CD62P) is present within platelet a-granules and is
externalized upon platelet activation. Five days after PbA infection,
we observed a lower frequency of P-selectin1 platelets in blood
from Nbeal22/2 mice compared with control mice as expected
(Figure 1D, left graph). To determine more broadly if Nbeal2
deficiency affected overall platelet activation, we analyzed surface
expression of 2 a-granule–independent markers of platelet activation:
CD63, which is present in dense granules and lysosomes and
externalized upon platelet activation,18 and the high-affinity confor-
mation of the integrin aIIbb3 (CD41/CD61).19 Similar to our findings
with P-selectin, we observed a significantly lower frequency of
CD631 and CD41/CD611 platelets isolated from Nbeal22/2 mice
at day 5 after PbA infection compared with control mice (Figure 1D,
middle graphs) despite Nbeal22/2 mice containing more platelets at
this time point (Figure 1D, right graph). The dysfunctional platelet
a-granule secretion in Nbeal22/2 mice was further validated by the
presence of significantly lower concentrations of PF4 in Nbeal22/2
plasma compared with C57BL/6J control plasma both in naive mice
and in mice at day 6 after infection with PbA (Figure 1E). Of note,
PbA-infected mice have significantly less plasma PF4 than naive
mice given the significant reduction in the platelet count that occurs
by day 6 after infection (Figure 1A). Taken together, these data
suggest that Nbeal2 deficiency affects platelet activation as a whole
in the context of severe malaria, which may subsequently influence
the ability of Nbeal22/2 platelets to interact with iRBCs.
Although we found that platelet a-granules do not inhibit PbA
blood-stage parasite growth (Figure 1C, right), peripheral parasitemia
does not reflect the quantity of iRBCs, specifically schizonts, that
have sequestered in the microvasculature of organs. Therefore, we
quantified iRBC sequestration in key organs of Nbeal22/2 mice as
measured by bioluminescence of a schizont-specific luciferase-
expressing PbA strain. The spleen, which is responsible for iRBC
clearance and activation of the immune response against iRBCs,20
contained significantly fewer iRBCs in Nbeal22/2 mice when
compared with C57BL/6J mice (Figure 1F). PbA sequestration
has been associated with acute lung injury,15 yet there was no
significant effect of platelet dysfunction on lung parasite seques-
tration in the absence of Nbeal2 (Figure 1G). However, we did
observe significant differences in brain parasite sequestration
which has been associated with ECM,21,22 as Nbeal22/2 mice
harbored significantly fewer parasites in the brain than control
mice (Figure 1H). Therefore, while platelets do not appear to
alter blood-stage PbA growth, platelet a-granules can potentiate
PbA organ sequestration.
PbA-induced lung and brain damage are associated with ECM,23
although the contribution of platelets to these events has not been
fully elucidated. Since parasite sequestration does not always
correlate with ECM development,24 we determined whether
reduced parasite sequestration was accompanied by reduced
pathology in these key organs. Malaria-induced vascular perme-
ability was significantly abrogated in both the lungs (Figure 1I) and
brains (Figure 1J) of Nbeal22/2 mice compared with control mice
at day 6 after infection with PbA.
Strikingly, this protection from lung and brain damage correlated
with nearly complete protection from ECM-associated death in
Nbeal22/2 mice (Figure 1K). Thus, platelet a-granules appear to
impact parasite sequestration and contribute to fatal Plasmodium-
associated organ damage during ECM.
Several recent studies have described abnormalities in neutrophils
and monocytes in Nbeal22/2mice in response to different pathogenic
infections.25,26 We also observed differences in neutrophil and
monocyte trafficking in PbA-infected mice, with Nbeal22/2 mice
harboring significantly more neutrophils and inflammatory monocytes
Figure 2. (continued) on day 0 of PbA infection. (B) Frequency of infected RBCs in peripheral blood of C57BL/6J mice given either an isotype control or anti-CD41
(a-CD41) antibody and diphtheria toxin–treated (1) MK and (2) MK mice at day 6 after infection with PbA as determined by staining and counting of thin blood smears
(n 5 14-20 mice/group). (C-E) Bioluminescence quantification of sequestered PbA schizonts expressing luciferase under the AMA-1 promoter in spleens (C), lungs (D), and
brains (E) of PbA-infected mice in designated groups (n 5 8-9 mice/group). Values are normalized to naı¨ve control mice from each respective group (n 5 4 mice/group). (F-G)
Lung permeability (F) and brain permeability (G) in platelet-intact and depleted mice as described in panel A injected IV with 200 mL of 1% Evans blue dye at day 6 after
infection with PbA (n 5 7-11 mice/group). Representative images and quantification of dye extracted from whole organs are shown. Optical density values are normalized to
naive control mice from each respective group (n 5 4-5 mice/group). (H) Survival curves of PbA-infected C57BL/6J mice given an anti-CD41 (a-CD41, red line) or isotype
control (green line) antibody on day 1 after infection (n 5 15-21 mice/group). (I) Survival curves of PbA-infected (2) MK (blue line) and (1) MK (green line) mice given
diphtheria toxin on days 27, 24, and 21 prior to infection (n 5 11-13 mice/group). The gray shaded regions represent the typical timeframe of death from ECM. Bar graphs in
panels A-B and F-G represent the mean 6 standard error of the mean. Boxes in panels C-E represent the median 6 the 25th and 75th percentiles with minimum/maximum
whiskers. Statistical analyses were performed using the Mann-Whitney U test for isotype/a-CD41 and (1) MK/(2) MK groups, respectively (as separated by gray dotted line)
(A-G) and log-rank Mantel-Cox test (H-I). Only statistically significant (P , .05) values are shown. Figures represent combined data from 2 (C-G,I) or $3 (A-B,H) independent
experiments. FSC, forward scatter.
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in the spleen when compared with PbA-infected C57BL/6J control
mice (supplemental Figure 2A). However, the numbers of neutrophils
present in the lungs and brains of PbA-infected Nbeal22/2 and
C57BL/6J mice were similar (supplemental Figure 2B-C, left
graphs). PbA-infected Nbeal22/2 mice had a significantly higher
frequency and number of inflammatory monocytes in their lungs
compared with PbA-infected C57BL/6J control mice (supple-
mental Figure 2B, right graphs). Previous studies have shown
that inflammatory monocytes play a key role in the clearance of
organ-sequestered PbA-iRBCs that can help minimize organ
damage.14 Thus, it is possible that the increase in inflammatory
monocytes in the spleens of Nbeal22/2 mice could participate in
reducing parasite sequestration, although this does not appear
to be the case in the lungs where parasite sequestration was
not significantly affected by Nbeal2 deficiency. Furthermore,
Nbeal22/2 mice also experienced significantly reduced brain
parasite sequestration and pathology in the absence of any
difference in brain inflammatory monocyte numbers (supplemental
Figure 2C, right graphs). It therefore seems unlikely that these
observed differences in monocytes are responsible for the
protective phenotype observed in Nbeal22/2 mice. Similarly,
although neutrophils have been shown in a few studies to poten-
tially contribute to Plasmodium-associated lung and brain damage
in severe malaria,27,28 the fact that we observed no significant
differences in neutrophil numbers in the lungs or brains of
PbA-infected Nbeal22/2 mice compared with C57BL/6J mice
also suggests that the reduced organ damage is independent
of any effects of Nbeal2 deficiency on neutrophil function. In
support of this, there were no significant differences in the levels
of myeloperoxidase or elastase in the plasma of PbA-infected
Nbeal22/2 and C57BL/6J mice at day 6 after infection (supplemen-
tal Figures 2D-E). This suggests similar systemic neutrophil
activation at the onset of severe disease, even though naive
Nbeal22/2 mice have significantly higher levels of both enzymes
compared with naive C57BL/6J mice, as has been described
previously.26
Given the clearly reduced organ pathology and enhanced survival
in PbA-infected Nbeal22/2 mice, we next determined if we could
recapitulate the impacts of Nbeal2 deficiency using 2 different
mouse models of platelet deficiency. The first involves administering
an anti-CD41 antibody to deplete platelets, which has been shown
to protect against ECM.12 The second model, which has not been
previously used in any Plasmodium studies, involves mice that
selectively express DTR on megakaryocytes, allowing for inducible
megakaryocyte depletion and reduced platelet production.29 Flow
cytometry confirmed that platelets are depleted equivalently in
anti-CD41 (a-CD41) and (2) MK mice (Figure 2A). As in Nbeal22/2
mice, peripheral parasite growth at day 6 after infection was
unaffected by the absence of platelets (Figure 2B), further
demonstrating the minimal role that platelets play in controlling
PbA peripheral parasite growth. Similar to Nbeal22/2 mice,
platelet-depleted mice had reduced splenic parasite accumula-
tion (Figure 2C), although this trend was not significant in (2)
MK mice. We found no significant differences in PbA para-
site burden in the lungs or brains of platelet-depleted mice
compared with their respective platelet-intact control groups
(Figure 2D-E). Additionally, aside from a slight but significant
difference in lung parasite burden at day 2 after infection,
we observed no clear effects of platelet depletion on parasite
sequestration at earlier time points after infection prior to day 6
(supplemental Figure 3A-C). Along with the data shown in Figure 1,
these data collectively suggest a more complex role for platelets in
mediating parasite trafficking and/or sequestration during PbA
infection.
Despite similar parasite burdens, Plasmodium-induced vascular
permeability in both the lungs (Figure 2F) and brain (Figure 2G)
was significantly reduced in both models of induced thrombo-
cytopenia. As with Nbeal2 deficiency, platelet-depleted mice
also experienced significantly improved survival from ECM in
both models (Figure 2H-I), although the magnitude of survival
varied. This suggests that the method and timing of platelet
depletion impacts ECM development.
In summary, our results show that Nbeal22/2 mice are robustly
protected from the organ damage and death characteristic of
PbA infection, suggesting the importance of platelet a-granules
in contributing to severe malaria pathology. These effects of Nbeal2
deficiency are largely recapitulated by platelet depletion. As
Nbeal22/2 mice harbor dysfunctional platelets from birth while
a-CD41–treated mice and diphtheria toxin–treated (2) MK mice
experience transient platelet depletion as adults, it is likely the
differences among the 3 models of platelet dysfunction/depletion
can potentially be attributed to the timing, magnitude, and/or
mechanism of platelet depletion. The differing extents of brain
parasite sequestration and survival in a-CD41 and (2) MK mice
indicate that the methodology of platelet depletion itself may
impact severe malaria pathology. Dysfunctional platelets in Nbeal22/2
mice may be able to recruit immune cells to sites of parasite
sequestration during early PbA infection in an a-granule–independent
manner30 benefitting the early response to infection. On the other
hand, their lack of a-granules may render them unable to recruit
pathogenic CD8 T cells to organs,31 which is required for ECM-
associated pathology. Interestingly, the absence of any in vivo
increase in peripheral parasitemia in any of our mouse models of
platelet dysfunction/depletion contrasts with several studies that
suggest platelets are a central mechanism responsible for killing
iRBCs.5,32 However, those studies primarily involve nonsevere
malaria models in which the kinetics of the parasite-induced
inflammatory milieu likely have significant impacts on the timing of
platelet activation and their subsequent response to infection.
While additional research is required to continue to elucidate the
complex roles of platelets in malaria, this study further supports
a pathogenic role for platelets, particularly platelet a-granules, in
the development of severe malaria.
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